Skip to main content
Clinical Trials/NL-OMON25331
NL-OMON25331
Completed
N/A

The effectiveness of a tailored intervention program on return-to-work in unemployed sick-listed cancer patients and survivors: A randomized controlled trial.

VU University Medical Centre/EMGO+ Institute0 sites164 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer patients, cancer survivors, return-to-work, intervention, tailored intervention program, social security safety netter, unemployed, temporary agency worker, sickness benefit, social security agency. Kanker, kankerpatiënten, werkhervatting, terugkeer naar werk, interventie, interventieprogramma, ondersteuning, werklozen, uitzendkrachten, einde-dienstverbanders, vangnetters, uitkering, UWV.
Sponsor
VU University Medical Centre/EMGO+ Institute
Enrollment
164
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
VU University Medical Centre/EMGO+ Institute

Eligibility Criteria

Inclusion Criteria

  • Patients and survivors are eligible to participate in this study, when they are between 18 and 60 years old, when they have a primary diagnosis of cancer and when this diagnosis is registered at UWV, as the main cause for their sick\-leave. Furthermore, they must be registered at UWV as a social security safety netter without an employment contract; they must have applied for a sickness benefit and they must be at sick leave for at least 3 months up to 18 months. Patients will be included if they are receiving treatment with curative intent, defined as a 1 year survival rate of ca. 80% at time of diagnosis. In case a patient is still undergoing intensive cancer treatment (chemotherapy, radiotherapy, surgery or a combination of those), he/she will be included at a minimum of 6 weeks after finishing these treatments.
  • Amendment 21\-dec\-2014: They must have applied for sickness or disability benefits and
  • must be on sick leave for at least 12 months up to 36 months. Patients will be included if their
  • health status allows them to participate in the study (based on self\-report by the cancer
  • survivor) and if they have no comorbidities (e.g., severe psychological or physical conditions)
  • that would interfere with participating in this study (based on report from the cancer survivor’s
  • general practitioner (GP)).

Exclusion Criteria

  • Patients will be excluded in case of comorbidity of such kind that participating in the tailored intervention program is not possible (assessment by participants’ general physician), in case of serious psychiatric disorders, in case of pregnancy, in case of a lack of knowledge of the Dutch language and/or in case of a conflict with UWV regarding a (previous) sickness benefit claim or a long\-term disability claim. Additionally, patients will be excluded if they are participating or signed up to be participating in a concurrent scientific study and/or re\-integration/rehabilitation program.

Outcomes

Primary Outcomes

Not specified

Similar Trials